It has been …
… since President Joe Biden said "Ending this pandemic means ending it everywhere."
We need at least US $52 billion to fund the global response to the COVID-19 pandemic in 2022. Grant financing by donor countries accounts for at least US $27.7 billion, or 53%, of this. Governments must act fast to fill this funding gap. To date, US $2.3 billion has been committed by members of the G20.
US $17 billion fair share ask
US $428.5 million contributedas of 23 March 2022
3% of fair share contributed
Only a handful of countries have the capacity to manufacture vaccines. We need urgent action to share mRNA technology and intellectual property rights, and to adapt existing facilities and acquire the materials needed to scale up vaccine production globally.
Endorsed the TRIPS waiver
on 30 September 2021
Is supporting efforts to increase regional manufacturing capacity
as of 30 June 2021
The pandemic’s aftershocks continue to devastate the economies of many countries. High-income countries must support more vulnerable nations with all tools available, including Special Drawing Rights (SDRs), an international reserve asset that can help support countries in emergencies. Rechannelling an initial $100 billion of SDRs in 2021 to low income and vulnerable middle income countries is a smart investment in a fairer, greener, and better recovery for everyone. To date, $60 billion has been committed from all advanced economies.
US $113 billion receivedon 23 August 2021
US $0 billion pledged
0% of fair share of $100bn SDR recycling in 2021
US $3.5 billion pledged
on on 15 December 2021
17% above IDA19 pledge
Does not support ambitious IDA replenishment/$100bn ask
Low and lower-middle income countries still need nearly 2.2 billion doses to fully vaccinate 70% of the population by mid-2022. To help close the gap, members of the G20 have promised to share over 2.7 billion doses by mid-2022. To date, 1.17 billion have been delivered. Note: in response to calls from Africa CDC to pause vaccine donations until the second half of 2022, scoring for the delivery of doses was last updated on 17 February 2022 to reflect how well donors delivered on commitments when there were significant constraints on the supply of COVID-19 vaccines. Deliveries and updates to published dose delivery will continue to be monitored.
The United States has not published a dose delivery plan.
1.1 billion pledgedon 22 September 2021
526.3 million deliveredas of 19 May 2022
The US has committed to sharing 1.1 billion doses. It delivered the promised 280 million doses by the end of 2021. President Joe Biden also hosted a meeting in September 2021 to kick start a global effort to vaccinate 70% of the population in each income category by September 2022.
The US was also the largest foreign aid donor in 2020, providing a total of $35.5 billion, an increase of almost 5%. Still, the US committed only $6.2 billion to the Access to COVID-19 Accelerator (ACT-A) in 2021, short of the $9.8 billion it was asked to pledge.
The current US administration was also critical in moving the historic allocation of $650 billion in new Special Drawing Rights (SDRs) in 2021 and has pressed wealthy countries to recycle those SDRs to countries in need. The US must now commit the dollars necessary to get COVID-19 vaccines into arms, to develop therapeutics and save lives now, and to establish a financing mechanism to beat future pandemics.